Host–biomaterial interactions in mesh complications after pelvic floor reconstructive surgery

Roxanna E. Abhari,Matthew L. Izett-Kay,Hayley L. Morris,Rufus Cartwright,Sarah J. B. Snelling
DOI: https://doi.org/10.1038/s41585-021-00511-y
2021-09-20
Nature Reviews Urology
Abstract:Polypropylene (PPL) mesh is widely used in pelvic floor reconstructive surgery for prolapse and stress urinary incontinence. However, some women, particularly those treated using transvaginal PPL mesh placement for prolapse, experience intractable pain and mesh exposure or extrusion. Explanted tissue from patients with complications following transvaginal implantation of mesh is typified by a dense fibrous capsule with an immune cell-rich infiltrate, suggesting that the host immune response has a role in transvaginal PPL mesh complications through the separate contributions of the host (patient), the biological niche within which the material is implanted and biomaterial properties of the mesh. This immune response might be strongly influenced by both the baseline inflammatory status of the patient, surgical technique and experience, and the unique hormonal, immune and microbial tissue niche of the vagina. Mesh porosity, surface area and stiffness also might have an effect on the immune and tissue response to transvaginal mesh placement. Thus, a regulatory pathway is needed for mesh development that recognizes the roles of host and biological factors in driving the immune response to mesh, as well as mandatory mesh registries and the longitudinal surveillance of patients. Complications related to the use of mesh in pelvic floor reconstructive surgery are related to a number of factors. This Review discusses the foreign body response, the biomaterial properties of mesh, the patient-specific and surgical risk factors and the failings in mesh development, all of which have contributed to these complications.
urology & nephrology
What problem does this paper attempt to address?